Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients

Saved in:
Bibliographic Details
Published in:PLOS ONE
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870206699027038208
collection WordPress RSS
FRELIP Feed Integration
container_title PLOS ONE
description
discipline_display Open Access Journals
discipline_facet Open Access Journals
format Online Article
RSS Article
genre Journal Article
id rss_article:101025
institution FRELIP
journal_source_facet PLOS ONE
last_indexed 2026-07-09T03:34:54.989Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
Open Access Journals
General
Open Access Journals
sub_discipline_display General
sub_discipline_facet General
subject_display Open Access Journals
General
Open Access Journals
subject_facet Open Access Journals
General
Open Access Journals
title Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_alt El ADN libre de células plasmáticas medido antes del inicio de la terapia de reemplazo renal no se asocia con resultados adversos incidentes, hospitalizaciones o neoplasias malignas en pacientes con enfermedad renal crónica en etapa 4-5
L'ADN acellulaire plasmatique mesuré avant l'initiation de la thérapie de remplacement rénal n'est pas associé à des événements indésirables incidents, des hospitalisations ou des tumeurs malignes chez les patients atteints d'insuffisance rénale chronique de stade 4-5
DNA livre de células plasmáticas medido antes do início da terapia de substituição renal não está associado a desfechos adversos incidentes, hospitalizações ou malignidades em pacientes com doença renal crônica estágio 4–5
title_auth Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_es_txt El ADN libre de células plasmáticas medido antes del inicio de la terapia de reemplazo renal no se asocia con resultados adversos incidentes, hospitalizaciones o neoplasias malignas en pacientes con enfermedad renal crónica en etapa 4-5
title_fr_txt L'ADN acellulaire plasmatique mesuré avant l'initiation de la thérapie de remplacement rénal n'est pas associé à des événements indésirables incidents, des hospitalisations ou des tumeurs malignes chez les patients atteints d'insuffisance rénale chronique de stade 4-5
title_full Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_fullStr Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_full_unstemmed Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_pt_txt DNA livre de células plasmáticas medido antes do início da terapia de substituição renal não está associado a desfechos adversos incidentes, hospitalizações ou malignidades em pacientes com doença renal crônica estágio 4–5
title_short Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
title_sort plasma cell-free dna measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
topic Open Access Journals
General
Open Access Journals
url https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0353258